Effects of 8-OHDPAT and 5-HT1A antagonists WAY100135 and WAY100635, on guinea-pig behaviour and dorsal raphe 5-HT neurone firing

British Journal of Pharmacology

Volumn 117, Issue 4, 1996, Pages 750-756

  Mundey, M K ^a   Fletcher, A ^b,c   Marsden, C A ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b PFIZER INC   (United States)

^c NONE   (United Kingdom)

Author keywords

5 Ht1A antagonists; 8 OHDPAT; Behavioural syndrome in guinea pig; Dorsal raphe nucleus; Somatodendritic autoreceptor; WAY100135; WAY100635

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; KETANSERIN; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N TERT BUTYL 3 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL] 2 PHENYLPROPIONAMIDE; SEROTONIN 1A RECEPTOR; SEROTONIN 2 RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; COMPETITIVE INHIBITION; DORSAL RAPHE NUCLEUS; DRUG ANTAGONISM; GUINEA PIG; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; SEROTONIN RELEASE; SUBCUTANEOUS DRUG ADMINISTRATION;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ACTION POTENTIALS; ANIMALS; BEHAVIOR, ANIMAL; CARBIDOPA; GUINEA PIGS; KETANSERIN; MALE; NEURONS; PIPERAZINES; PYRIDINES; RAPHE NUCLEI; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 0029670670     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15254.x     Document Type: Article

References (41)

1. 1A receptor antagonist UH-301 and (R)-8-OHDPAT on the activity of dorsal raphe (DRN) 5HT neurones and dopamine neurones in the ventral tegmental area (VTA). In Serotonin: Animal Models and Clinical Targets. 3rd ITEM-Labo-Symp, Paris, Vol. 3, P. 12.
2. ARVIDSSON, L.E., HACKSELL, U., LARS, J., NILSSON, G., HJORTH, CARLSSON, A., LINDBERG, P., SANCHEZ, D. & WIKSTROM, H. (1981). 8-hydroxy-2-(di-n-propylamino) tetralin a new centrally acting 5-hydroxytryptamine receptor agonist. J. Med. Chem., 24, 921-923.
3. 2 receptor subtypes: a family re-united? Trends Pharmacol. Sci., 16, 105-110.
4. BEDARD, P. & PYCOCK, C.J. (1977). 'Wet-dog' shake behaviour in the rat: a possible quantitative model of central 5-hydroxytryptamine activity. Neuropharmacol., 16, 663-670.
5. 1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropyl-amino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropyl-amino)tetralin induced effects. J. Pharmacol. Exp. Ther., 258, 58-65.
6. CHADWICK, D., HALLET, M., JENNER, P. & MARSDEN, C.D. (1978). 5-Hydroxytryptophan-induced myoclonus in guinea-pigs. J. Neurolog. Sci., 35, 157-165.
7. DEAKIN, J.F.W. & GREEN, A.R. (1978). The effects of putative 5-hydroxytryptamine antagonists on the behaviour produced by administration of tranylcypromine and L-tryptophan or L-dopa to rats. Br. J. Pharmacol., 64, 201-209.
8. DOURISH, C.T., HUTSON, P.H. & CURZON, G. (1985). Characteristics of feeding induced by the serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OHDPAT). Brain Res. Bull., 15, 377-384.
9. 1A receptors. Eur. J. Pharmacol., 237, 283-291.
10. 1A receptor antagonist. Br. J. Pharmacol., 112, 92P.
11. 1A receptor antagonists: utility as research tools and therapeutic agents. Trends Pharmacol. Sci., 14, 441-448.
12. FONE, K.C.F., ROBINSON, J. & MARSDEN, C.A. (1991). Characterization of the 5-HT receptor subtypes involved in the motor behaviours produced by intrathecal administration of 5-HT agonists in rats. Br. J. Pharmacol., 104, 1547-1555.
13. FORNAL, C.A., LITTO, W.J., RIBEIRO-DO-VALLE, L.E. & JACOBS, B.L. (1989). Role of somatodendritic autoreceptors in the regulation of serotonergic neuronal activity in behaving cats. Soc. Neurosci. Abstr., 15, 225.4.
14. FORNAL, C.A., METZLER, C.W., VEASEY, S.A., McCREARY, A.C., DOURISH, C.T. & JACOBS, B.L. (1994). Single unit studies in behaving animals provide evidence that WAY100635, but not (S)-WAY100635 blocks the action of endogenous serotonin at the 5HT autoreceptor. Br. J. Pharmacol., 112, 92P.
15. GRAHAME-SMITH, D.G. (1971a). Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibition and L-tryptophan. J. Neurochem., 18, 1053-1066.
16. GRAHAME-SMITH, D.G. (1971b). Inhibitory effect of chlorpromazine on the syndrome of hyperactivity produced by L-tryptophan or 5-methoxy-N,N-dimethyl tryptamine in rats treated with a monoamine oxidase inhibitor. Br. J. Pharmacol., 43, 856-864.
17. GREEN, A.R., HALL, J.E. & REES, A.R. (1981). A behavioural and biochemical study in rats of 5-hydroxytryptamine agonists and antagonists with observations on structure activity requirements for agonists. Br. J. Pharmacol., 73, 703-719.
18. GREEN, A.R., TORDOFF, A.F.C. & BLOOMFIELD, M.R. (1976). Elevation of brain GABA concentrations with amino-oxyacetic acid: effect on the hyperactivity syndrome produced by increased 5-hydroxytryptamine synthesis in rats. J. Neural Trans., 39, 103-112.
19. 1A receptor antagonist WAY100635 on hippocampal 5HT release in vivo. Br. J. Pharmacol., 112, 299P.
20. 1A antagonist is determined by arousal state. J. Psychopharmacol., Abstract A13.
21. 1B receptor binding sites in brain? Trends Pharmacol. Sci., 7, 336-338.
22. 2 agonist. Br. J. Pharmacol., 94, 399P.
23. HESS, S.M. & DOEPFNER, W. (1961). Behavioural effects and brain amine content in rats. Arch. Int. Pharmacodynam. Ther., 134, 89-99.
24. HJORTH, S., CARLSSON, A., LINDBERG, P., SANCHEZ, D., WIKSTROM, H., ARVIDSSON, L.E., HACKSELL, U. & NILSSON, J.L.G. (1982). 8-hydroxy-2-(di-n-propylamino) tetralin, 8-OHDPAT, a potent and selective simplified ergot congener with central 5HT receptor stimulating activity. J. Neural. Transm., 55, 169-188.
25. 1A receptors in the brain. Nauyn-Schmied. Arch. Pharmacol., 347, 453-463.
26. KLAWANS, H.L., GOETZ, C. & WEINER, W.J. (1973). 5-Hydroxytryptophan-induced myoclonus in guinea-pigs and the possible role of serotonin in infantile myoclonus. Neurology, 23, 1234-1240.
27. LOVENBERG, T.W., BARON, B.M., DE LECEA, L., MILLER, J.D., PROSSER, R.A., REA, M.A., FOYE, P.E., RACKE, M., SLONE, A.M., SIEGAL, B.W., DANIELSON, P.E., SUTCLIFFE, J.G. & ERLANDER, M.G. (1993). A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms. Neuron, 11, 449-458.
28. LUSCOMBE, G.P., JENNER, P. & MARSDEN, C.D. (1981). Pharmacological analysis of the myoclonus induced by 5-hydroxytryptophan in the guinea-pig suggests the presence of multiple 5-hydroxytryptophan receptors in the brain. Neuropharmacol., 20, 819-831.
29. LUSCOMBE, G.P., JENNER, P. & MARSDEN, C.D. (1982a). Myoclonus in guinea-pigs is induced by indole-containing but not piperazine-containing 5HT agonists. Life Sci., 30, 1487-1494.
30. LUSCOMBE, G.P., JENNER, P. & MARSDEN, C.D. (1982b). Tryptamine-induced myoclonus in guinea-pigs pretreated with a monoamine oxidase inhibitor indicates pre- and post-synaptic actions of tryptamine upon central indoleamine systems. Neuropharmacol., 21, 1257-1265.
31. 2 binding sites with those of serotonin autoreceptors which modulate serotonin release. Nauyn-Schmied. Arch. Pharmacol., 342, 165-170.
32. 1A antagonists SDZ 216-525 and WAY100135 on neuronal firing in the guinea-pig dorsal raphe nucleus. Neuropharmacol., 33, 61-66.
33. 1A antagonist WAY100635 on 5HT neuronal firing in the guinea-pig dorsal raphe nucleus. Br. J. Pharmacol., 112, 93P.
34. 2 antagonists. Drug Dev. Res., 3, 123-135.
35. ORTMANN, R., WALDMEIER, P.C., RADEKE, E., FELNER, A. & DELINI-STULA, A. (1980). The effects of 5HT uptake and monoamine oxidase inhibitors on L-5HTP-induced excitation in rats. Naunyn-Schmied. Arch. Pharmacol., 311, 185-192.
36. 2 receptor antagonists. J. Psychopharmacol., 5, 196-201.
37. 1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino) tetralin. Eur. J. Pharmacol., 106, 271-282.
38. TRULSON, M.E. & JACOBS, B.L. (1976a). Dose-response relationships between systematically administered L-tryptophan or L-5-hydroxytryptophan and raphe unit activity in rat. Neuropharmacol., 15, 339-344.
39. TRULSON, M.E. & JACOBS, B.L. (1976b). Behavioural evidence for the rapid release of CNS serotonin by PCA and fenfluramine. Eur. J. Pharmacol., 36, 149-154.
40. VOLKMAN, P.H., LORENS, S.A., KINDEL, G.H. & GINOS, J.Z. (1978). L-5-hydroxytryptophan-induced myoclonus in guinea-pigs: a model for the study of central serotonin-dopamine interactions. Neuropharmacol., 17, 947-955.
41. YAMADA, J., SUGIMOTO, Y. & KAZUYOSHI, H. (1988). The behavioural effects of 8-hydroxy-2(di-n-propylamino) tetralin (8-OHDPAT) in mice. Eur. J. Pharmacol., 154, 299-304.